Aizawa Y, Izumita R, Saitoh A. Human parechovirus type 3 infection: An emerging infection in neonates and young infants. J Infect Chemother. 2017;23:419–26.

Article  PubMed  Google Scholar 

Harvala H, Robertson I, Chieochansin T, McWilliam Leitch EC, Templeton K, Simmonds P. Specific association of human parechovirus type 3 with sepsis and fever in young infants, as identified by direct typing of cerebrospinal fluid samples. J Infect Dis. 2009;199:1753–60.

Article  CAS  PubMed  Google Scholar 

Wigand R, Sabin AB. Properties of ECHO types 22, 23 and 24 viruses. Arch Gesamte Virusforsch. 1961;11:224–47.

Article  CAS  PubMed  Google Scholar 

Hyypia T, Horsnell C, Maaronen M, Khan M, Kalkkinen N, Auvinen P, et al. A distinct picornavirus group identified by sequence analysis. Proc Natl Acad Sci U S A. 1992;89:8847–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghazi F, Hughes PJ, Hyypiä T, Stanway G. Molecular analysis of human parechovirus type 2 (formerly echovirus 23). J Gen Virol. 1998;79(Pt 11):2641–50.

Article  CAS  PubMed  Google Scholar 

Ito M, Yamashita T, Tsuzuki H, Takeda N, Sakae K. Isolation and identification of a novel human parechovirus. J Gen Virol. 2004;85:391–8.

Article  CAS  PubMed  Google Scholar 

Boivin G, Abed Y, Boucher FD. Human parechovirus 3 and neonatal infections. Emerg Infect Dis. 2005;11:103–5.

Article  PubMed  PubMed Central  Google Scholar 

Schuffenecker I, Javouhey E, Gillet Y, Kugener B, Billaud G, Floret D, et al. Human parechovirus infections, Lyon, France, 2008-10: evidence for severe cases. J Clin Virol. 2012;54:337–41.

Article  PubMed  Google Scholar 

Selvarangan R, Nzabi M, Selvaraju SB, Ketter P, Carpenter C, Harrison CJ. Human parechovirus 3 causing sepsis-like illness in children from midwestern United States. Pediatr Infect Dis J. 2011;30:238–42.

Article  PubMed  Google Scholar 

Renaud C, Kuypers J, Ficken E, Cent A, Corey L, Englund JA. Introduction of a novel parechovirus RT-PCR clinical test in a regional medical center. J Clin Virol. 2011;51:50–3.

Article  PubMed  Google Scholar 

Walters B, Penaranda S, Nix WA, Oberste MS, Todd KM, Katz BZ, et al. Detection of human parechovirus (HPeV)-3 in spinal fluid specimens from pediatric patients in the Chicago area. J Clin Virol. 2011;52:187–91.

Article  CAS  PubMed  Google Scholar 

Felsenstein S, Yang S, Eubanks N, Sobrera E, Grimm JP, Aldrovandi G. Human parechovirus central nervous system infections in southern California children. Pediatr Infect Dis J. 2014;33:e87–91.

Article  PubMed  Google Scholar 

Midgley CM, Jackson MA, Selvarangan R, Franklin P, Holzschuh EL, Lloyd J, et al. Severe Parechovirus 3 Infections in Young Infants-Kansas and Missouri, 2014. J Pediatric Infect Dis Soc. 2018;7:104–12.

Article  PubMed  Google Scholar 

Sasidharan A, Banerjee D, Harrison CJ, Selvarangan R. Emergence of Parechovirus A3 as the Leading Cause of Central Nervous System Infection, Surpassing Any Single Enterovirus Type, in Children in Kansas City, Missouri, USA, from 2007 to 2016. J Clin Microbiol. 2021;59.

Lee BR, Sasidharan A, Harrison CJ, Selvarangan R. Disruption of seasonal enterovirus and parechovirus detections in the CSF and plasma of children during the COVID-19 pandemic. J Clin Virol. 2023;160:105381. A recent study demonstrating an impact of COVID-19 on the detection of enterovirus and parechovirus from children in the US.

Tao L, Humphries RM, Banerjee R, Gaston DC. Re-emergence of Parechovirus: 2017-2022 National Trends of Detection in Cerebrospinal Fluid. Open Forum Infect Dis. 2023;10:ofad112. A recent study demonstrating reemergence of parechovirus in CSF detected by multiplex PCR in the US.

Harvala H, McLeish N, Kondracka J, McIntyre CL, McWilliam Leitch EC, Templeton K, et al. Comparison of human parechovirus and enterovirus detection frequencies in cerebrospinal fluid samples collected over a 5-year period in edinburgh: HPeV type 3 identified as the most common picornavirus type. J Med Virol. 2011;83:889–96.

Article  PubMed  Google Scholar 

Skram MK, Skanke LH, Krokstad S, Nordbo SA, Nietsch L, Dollner H. Severe parechovirus infection in Norwegian infants. Pediatr Infect Dis J. 2014;33:1222–5.

Article  PubMed  Google Scholar 

de Jong EP, van den Beuken MGA, van Elzakker EPM, Wolthers KC, Sprij AJ, Lopriore E, et al. Epidemiology of Sepsis-like Illness in Young Infants: Major Role of Enterovirus and Human Parechovirus. Pediatr Infect Dis J. 2018;37:113–8.

Article  PubMed  Google Scholar 

Cabrerizo M, Díaz-Cerio M, Muñoz-Almagro C, Rabella N, Tarragó D, Romero MP, et al. Molecular epidemiology of enterovirus and parechovirus infections according to patient age over a 4-year period in Spain. J Med Virol. 2017;89:435–42.

Article  CAS  PubMed  Google Scholar 

Linhares MI, Brett A, Correia L, Pereira H, Correia C, Oleastro M, et al. Parechovirus Genotype 3 Outbreak Among Young Infants in Portugal. Acta Med Port. 2021;34:664–8.

Article  PubMed  Google Scholar 

Elling R, Böttcher S, du Bois F, Müller A, Prifert C, Weissbrich B, et al. Epidemiology of Human Parechovirus Type 3 Upsurge in 2 Hospitals, Freiburg, Germany, 2018. Emerg Infect Dis. 2019;25:1384–8.

Article  PubMed  PubMed Central  Google Scholar 

Han TH, Chung JY, You SJ, Youn JL, Shim GH. Human parechovirus-3 infection in children. South Korea. J Clin Virol. 2013;58:194–9.

Article  PubMed  Google Scholar 

Aizawa Y, Watanabe K, Oishi T, Hirano H, Hasegawa I, Saitoh A. Role of Maternal Antibodies in Infants with Severe Diseases Related to Human Parechovirus Type 3. Emerg Infect Dis. 2015;21:1966–72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cumming G, Khatami A, McMullan BJ, Musto J, Leung K, Nguyen O, et al. Parechovirus Genotype 3 Outbreak among Infants, New South Wales, Australia, 2013-2014. Emerg Infect Dis. 2015;21:1144–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nelson TM, Vuillermin P, Hodge J, Druce J, Williams DT, Jasrotia R, et al. An outbreak of severe infections among Australian infants caused by a novel recombinant strain of human parechovirus type 3. Sci Rep. 2017;7:44423.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bialasiewicz S, May M, Tozer S, Day R, Bernard A, Zaugg J, et al. Novel Human Parechovirus 3 Diversity, Recombination, and Clinical Impact Across 7 Years: An Australian Story. J Infect Dis. 2023;227:278–87.

Article  PubMed  Google Scholar 

van der Sanden S, de Bruin E, Vennema H, Swanink C, Koopmans M, van der Avoort H. Prevalence of human parechovirus in the Netherlands in 2000 to 2007. J Clin Microbiol. 2008;46:2884–9.

Article  PubMed  PubMed Central  Google Scholar 

Watanabe K, Hirokawa C, Tazawa T. Seropositivity and epidemiology of human parechovirus types 1, 3, and 6 in Japan. Epidemiol Infect. 2016;144:3451–60.

Article  CAS  PubMed  Google Scholar 

Aizawa Y, Kasamatsu T, Nagasawa K, Watanabe K, Saitoh A. Molecular Evolution and Epidemiology of Parechovirus-A3 in Japan, 1997-2019. J Infect Dis. 2023;227:288-294. A recent study demonstrating molecular evolution and epidemiology of PeV-A3 in Japan for the last 2 decades.

Tao L, Fill MA, Banerjee R, Humphries RM. Notes from the Field: Cluster of Parechovirus Central Nervous System Infections in Young Infants - Tennessee, 2022. MMWR Morb Mortal Wkly Rep. 2022;71:977–8.

Article  PubMed  PubMed Central  Google Scholar 

Olijve L, Jennings L, Walls T. Human Parechovirus: an Increasingly Recognized Cause of Sepsis-Like Illness in Young Infants. Clin Microbiol Rev. 2018;31.

Sharp J, Bell J, Harrison CJ, Nix WA, Oberste MS, Selvarangan R. Human parechovirus in respiratory specimens from children in Kansas City, Missouri. J Clin Microbiol. 2012;50(12):4111–3.

Article  PubMed  PubMed Central  Google Scholar 

Izumita R, Deuchi K, Aizawa Y, et al. Intrafamilial transmission of parechovirus A and enteroviruses in neonates and young infants. J Pediatric Infect Dis Soc. 2019;8(6):501–6.

Article  PubMed  Google Scholar 

Westerhuis BM, Jonker SC, Mattao S, Benschop KS, Wolthers KC. Growth characteristics of human parechovirus 1 to 6 on different cell lines and cross- neutralization of human parechovirus antibodies: a comparison of the cytopathic effect and real time PCR. Virol J. 2013;10:146.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Klatte JM, Harrison CJ, Pate B, Queen MA, Neuhart J, Jackson MA, et al. Maternal parechovirus A (PeV-A) shedding, serostatus, and the risk of central nervous system PeV-A infections in infants. J Clin Virol. 2021;142:104939.

Article  PubMed  Google Scholar 

Karelehto E, Wildenbeest JG, Benschop KSM, Koen G, Rebers S, Bouma-de Jongh S, et al. Human Parechovirus 1, 3 and 4 Neutralizing Antibodies in Dutch Mothers and Infants and Their Role in Protection Against Disease. Pediatr Infect Dis J. 2018;37:1304–8.

Article  PubMed  PubMed Central  Google Scholar 

Tanaka S, Aoki Y, Matoba Y, Yahagi K, Itagaki T, Matsuzaki Y, et al. Seroepidemiology of human parechovirus types 1, 3, and 6 in Yamagata, Japan, in 2014. Microbiol Immunol. 2016;60:854–8.

Article  CAS  PubMed  Google Scholar 

Karelehto E, Brouwer L, Benschop K, Kok J, Basile K, McMullan B, et al. Seroepidemiology of Parechovirus A3 Neutralizing Antibodies, Australia, the Netherlands, and United States. Emerg Infect Dis. 2019;25:148–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shimizu H, Hashimoto K, Sato M, Sato A, Maeda H, Kyozuka H, et al. Association Between Neutralizing Antibody Titers against Parechovirus A3 in Maternal and Cord Blood Pairs and Perinatal Factors. J Pediatric Infect Dis Soc. 2020;9:320–5.

Article  CAS  PubMed  Google Scholar